Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?


BAĞCIOĞLU M., Surcel C., Ozcan S., Mirvald C., Karagoz M. A. , Karadag M. A. , ...Daha Fazla

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, cilt.89, sa.4, ss.282-286, 2017 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 89 Konu: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4081/aiua.2017.4.282
  • Dergi Adı: ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA
  • Sayfa Sayıları: ss.282-286

Özet

Objective: Androgen deprivation therapy (ADT) is commonly used as a first-line treatment for locally advanced and metastatic prostatic cancer (Pca). There is no consensus about which alternative treatment should be used after the failure of initial ADT. We aimed to investigate the effect of changes in treatment on PSA and testosterone levels.